Cargando…
‘Primed’ Mesenchymal Stem Cells: a Potential Novel Therapeutic for COVID19 Patients
The COVID19 pandemic, designated as a public health crisis by the World Health Organization (WHO), is rapidly spreading around the world impacting the health and economy of almost all the countries. The data of hospitalized COVID19 patients, especially those with serious illness, indicate the involv...
Autores principales: | Raza, Syed Shadab, Seth, Pankaj, Khan, Mohsin Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317273/ https://www.ncbi.nlm.nih.gov/pubmed/32592163 http://dx.doi.org/10.1007/s12015-020-09999-0 |
Ejemplares similares
-
Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment
por: Raza, Syed Shadab, et al.
Publicado: (2022) -
Mechanisms underlying dental-derived stem cell-mediated neurorestoration in neurodegenerative disorders
por: Raza, Syed Shadab, et al.
Publicado: (2018) -
In vivo priming of human mesenchymal stem cells with hepatocyte growth factor–engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair
por: Park, Bong-Woo, et al.
Publicado: (2020) -
Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19
por: Paris, Gustavo C., et al.
Publicado: (2021) -
Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem
Cells in COVID-19 Treatment
por: Fang, Yuyin, et al.
Publicado: (2023)